Safety profile of pharmacotherapy in paitionts with non-alcogolic fatty liver disease
NAFLD is a leader among chronic liver diseases worldwide. Polymorbidity of such patients requires the appointment of different groups of drugs. The quality of pharmacological correction, which is determined in achieving the desired therapeutic effect and the absence of adverse reactions of the thera...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Russo |
| 出版事項: |
Remedium Group LLC
2019-05-01
|
| シリーズ: | Медицинский совет |
| 主題: | |
| オンライン･アクセス: | https://www.med-sovet.pro/jour/article/view/3007 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|